Full history for every metric is available with a Kvantra account
Innlanz Limited (INL.AX)
Key financial summary
Financials in AUD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | AUD m | 34 | 31 | 23 | 1 | 2 | 3 | 4 |
| Operating profit | AUD m | -0 | -0 | |||||
| Net profit | AUD m | 3 | -0 | -5 | -6 | -1 | -0 | -1 |
| EPS reported | AUD | -0.00 | -0.00 | |||||
| Operating cashflow per share | AUD | -0.00 | -0.00 | |||||
| Capex per share | AUD | 0.00 | 0.00 | |||||
| FCF per share | AUD | -0.00 | -0.00 | |||||
| Free cash flow | AUD m | -0 | -1 | |||||
| Net debt | AUD m | 3 | 2 | |||||
| Book value equity | AUD m | 3 | 2 | |||||
| Book value per share | AUD | 0.01 | 0.01 | |||||
| Number of shares | m | 313.26 | 313.26 | |||||
| DPS (TTM paid) | AUD | 0.00 | 0.00 |
Financial summary
Financials in AUD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 3.21 | 1.14 | |||||
| P/S LTM | x | 3.32 | 0.72 | |||||
| P/FCF LTM | x | -90.42 | -4.94 | |||||
| EV/EBITDA LTM | x | -136.23 | -16.74 | |||||
| EV/Sales LTM | x | 4.28 | 1.15 | |||||
| Earnings Yield LTM | % | -3.23% | -10.04% | |||||
| FCF Yield | % | -1.11% | -20.25% | |||||
| Quality | ||||||||
| ROE | % | -10.37% | -10.02% | |||||
| ROIC | % | -2.83% | -2.83% | |||||
| Operating margin | % | -7.13% | -7.13% | |||||
| Gross margin | % | 97.86% | 97.86% | |||||
| FCF/Sales | % | -3.67% | -3.67% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +65.72% | +13.27% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.03 | -0.25 | |||||
| Net Debt/EBITDA | x | -30.47 | -30.47 | |||||
| EBIT/Net interest | x | -1.47 | -1.47 | |||||
| Net debt/market cap | % | 28.80% | 58.99% | |||||
| Net debt/Equity | x | 0.93 | 0.67 | |||||
| Gross debt/equity | x | 1.24 | 0.92 | |||||
Company overview
Based in Parramatta, Australia, Innlanz Limited oversees and possesses a hotel located in Hamilton, New Zealand. This entity, established in 2002, transitioned to its present name in November 2021, having previously been known as Mediland Pharm Limited. It operates as a subsidiary of Pacific Merchants Group Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Innlanz Limited (INL.AX)
Based in Parramatta, Australia, Innlanz Limited oversees and possesses a hotel located in Hamilton, New Zealand. This entity, established in 2002, transitioned to its present name in November 2021, having previously been known as Mediland Pharm Limited. It operates as a subsidiary of Pacific Merchants Group Limited.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free